Statistics for Application of an active comparator-based benefit-risk Assessment in evaluating clinical trial design features of a new chemical entity using a Bayesian decision-theoretic framework.

Total visits

views
Application of an active comparator-based benefit-risk Assessment in evaluating clinical trial design features of a new chemical entity using a Bayesian decision-theoretic framework. 49

Total visits per month

views
January 2024 1
February 2024 0
March 2024 4
April 2024 3
May 2024 1
June 2024 0
July 2024 0

File Visits

views
Goel_umn_0130E_11194.pdf 44

Top country views

views
United States 17
China 7
Ireland 4
Germany 2
Finland 2
United Kingdom 2
India 2
Singapore 2
Taiwan 2
Argentina 1
Hong Kong SAR China 1
Indonesia 1
Mongolia 1
Netherlands 1
Romania 1
Russia 1
South Africa 1
Zambia 1

Top city views

views
Ashburn 6
Dublin 3
Chicago 2
Annandale 1
Beijing 1
Boardman 1
Cape Town 1
Cary 1
Central 1
Cheltenham 1
Des Moines 1
Dongguan 1
Hinckley 1
Jakarta 1
Minneapolis 1
Mountain View 1
Saint Paul 1
Shenzhen 1
Singapore 1
Taichung 1
Taipei 1
Vladivostok 1
Zhengzhou 1